Requires health care practitioners prescribing opioid medications to limit amount of prescribed medication to seven-day supply, except in certain circumstances.
Impact
The intended impact of A289 is to mitigate the risks associated with opioid prescriptions, including addiction and overdose. By confining the amount of opioids that can be prescribed for a short-term treatment, the bill aims to reduce overexposure to these potentially addictive substances. The bill's stipulations for documenting patient assessments and treatment plans enhance the focus on responsible prescribing practices, contributing positively to public health efforts aimed at combating the opioid crisis while still allowing for necessary pain management.
Summary
Assembly Bill A289, proposed for the 2026 session, focuses on prescribing practices for opioid medications in New Jersey. The bill requires healthcare practitioners to limit the quantity of opioid prescriptions for acute pain to a maximum of seven days, with certain exceptions. Specifically, if a healthcare practitioner believes that a longer supply is medically necessary, they may prescribe beyond the seven-day limit, but this must be documented in the patient's medical record along with the rationale for this decision. The bill also mandates that practitioners conduct thorough medical histories and assessments before prescribing opioids, which includes documenting a patient's prior experiences with medications and their pain management preferences.
Contention
Despite the seeming benefits, there may be contention surrounding the bill, particularly from healthcare practitioners who may view restrictions on prescription duration as a limitation on their professional judgment. Critics could argue that strict limits might hinder the ability to provide adequate pain management for patients with chronic or severe acute conditions. Additionally, the requirement for extensive documentation may be seen as burdensome, increasing the administrative workload for healthcare providers. Opponents may call for a more balanced approach that allows healthcare providers the flexibility to make decisions based on individual patient needs without excessive regulatory constraints.
Carry Over
Requires health care practitioners prescribing opioid medications to limit amount of prescribed medication to seven day supply, except in certain circumstances.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.